The life expectancy in the Western world is increasing for a long time, which is the courtesy of a higher life standard, a more thorough hygiene, and, of course, the progress of modern medicine. Nevertheless, one of the illnesses that still proves to be a great challenge regardless of the recent advancements in medicine is cancer. Skin cancer is, according to the World Health Organization, the most common malignancy for the white population. The beginning of the paper offers a brief overview of the latest available information concerning epidemiology, aetiology, diagnostics, and treatment options for skin cancer, whereas the rest of the article deals with modern approaches to skin cancer treatment, highlighting recent development of nanotechnology based treatment approaches. Among these, we focus especially on the newest nanotechnological approaches combined with chemotherapy, a field which specialises in target specificity, drug release control, and real time monitoring with the goal being to diminish unwanted side effects and their severity, achieving a cheaper treatment and a generally more efficient chemotherapy. The field of nanotechnology is a rapidly developing one, judging by already approved clinical studies or by new theranostic agents that combine both the therapeutic and diagnostic modalities.
Despite the past two decades’ advancements, cancer treatment remains a challenge and a motivation for many researchers worldwide. New treatment possibilities are constantly arising and show promise in improving treatment effectiveness, survival rates, and the patient quality of life, while at the same time decreasing unwanted side effects.
This article is an overview of various types of skin cancer, their characteristics, prevalence, and currently used treatment methods, including modern nanotechnology based methods. The latter are constantly improving our treatment possibilities by taking advantage of the specific properties of nanoparticles as carriers and more efficient targeting of the specific properties of cancer cells. We conclude with several prospects of the future in skin cancer treatment
Commentary: Journal of Cancer Clinical Trials
Commentary: Journal of Cancer Clinical Trials
Review Article: Journal of Cancer Clinical Trials
Review Article: Journal of Cancer Clinical Trials
Commentary: Journal of Cancer Clinical Trials
Commentary: Journal of Cancer Clinical Trials
Commentary: Journal of Cancer Clinical Trials
Commentary: Journal of Cancer Clinical Trials
Scientific Tracks Abstracts: Journal of AIDS & Clinical Research
Scientific Tracks Abstracts: Journal of AIDS & Clinical Research
Scientific Tracks Abstracts: Journal of Advanced Practices in Nursing
Scientific Tracks Abstracts: Journal of Advanced Practices in Nursing
Scientific Tracks Abstracts: Journal of Advanced Practices in Nursing
Scientific Tracks Abstracts: Journal of Advanced Practices in Nursing
Posters & Accepted Abstracts: Journal of Advanced Practices in Nursing
Posters & Accepted Abstracts: Journal of Advanced Practices in Nursing
Scientific Tracks Abstracts: Journal of Advanced Practices in Nursing
Scientific Tracks Abstracts: Journal of Advanced Practices in Nursing
Journal of Cancer Clinical Trials received 95 citations as per Google Scholar report